UPDATE: Aegis Capital Lowers PT on Venaxis Following Recent Dilution
August 19, 2013 at 11:26 AM EDT
In a report published Monday, Aegis Capital analyst Raghuram Selvaraju reiterated a Buy rating on Venaxis (NASDAQ: APPY ), but lowered the price target $6.00 to $3.50. In the report, Aegis Capital noted, “We are reducing our price target on Venaxis, Inc. due to the dilution that occurred in the
